GRP78 play an important role in breast cancers that respond to anti-estrogen therapy

[News]

Researchers at Georgetown Lombardi Comprehensive Cancer Center have uncovered a single molecule they say is a major determinant of resistance to anti-estrogen therapy used to treat or prevent breast cancer in high-risk women.

More... (http://www.news-medical.net/news/20120703/GRP78-play-an-important-role-in-breast-cancers-that-respond-to-anti-estrogen-therapy.aspx)